Strid Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$404K Sell
337
-16
-5% -$16.3K 0.04% 61
2026
Q1
$325K Buy
353
+24
+7% +$24.3K 0.04% 63
2025
Q4
$354K Buy
+329
New +$315K 0.04% 61
2025
Q2
Sell
-186
Closed -$154K 68
2025
Q1
$154K Sell
186
-6
-3% -$4.99K 0.02% 58
2024
Q4
$148K Buy
+192
New +$159K 0.02% 58

Other funds holding LLY

Strid Group's LLY Position: Q2 2026 in Review

Strid Group reduced its Eli Lilly (LLY) stake by 4.5% in Q2 2026, selling an estimated $16.3K and leaving 337 shares worth $404K. The position accounts for 0.04% of the portfolio, ranked #61.

Strid Group first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Strid Group held 337 shares of Eli Lilly worth $404K as of Q2 2026.
  • Strid Group sold 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
  • Eli Lilly made up 0.04% of Strid Group's portfolio in Q2 2026, its #61 holding.
  • Strid Group first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strid Group's 13F filing for Q2 2026, filed 23 Jul 2026.